Bharat Parenterals Limited (BOM:541096)
India · Delayed Price · Currency is INR 1,249.25
-10.20 (-0.81%)
At close: May 5, 2026
Bharat Parenterals Market Cap
Bharat Parenterals has a market cap or net worth of 8.61 billion as of May 6, 2026. Its market cap has increased by 35.83% in one year.
Market Cap
8.61B
Enterprise Value
9.69B
Revenue
3.50B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,249.25
Market Cap Chart
Since March 21, 2018, Bharat Parenterals's market cap has increased from 914.45M to 8.61B, an increase of 841.52%. That is a compound annual growth rate of 31.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 8.61B | 3.29% |
| Dec 31, 2025 | 8.34B | -12.96% |
| Dec 31, 2024 | 9.58B | 103.12% |
| Dec 29, 2023 | 4.71B | 148.91% |
| Dec 30, 2022 | 1.89B | -13.76% |
| Dec 31, 2021 | 2.20B | 8.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 12.95B |
| Lincoln Pharmaceuticals | 12.93B |
| Syncom Formulations (India) | 12.91B |
| TTK Healthcare | 12.82B |
| Shukra Pharmaceuticals | 12.73B |
| Fredun Pharmaceuticals | 12.30B |
| Fermenta Biotech | 9.16B |
| Wanbury | 9.00B |